Evidence map›Paper›PMID 41754014›Full record

ArticleHealthcare (Basel, Switzerland)2026

Inequities in the Hypertension and Diabetes Care Cascade: A Comparison of SES and Insurance in China, the US, and the UK.

Yutong Nie, Qiaorong Huang, Wentong Meng, Xue Li, Lei Chen, Xianming Mo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yutong NieLaboratory of Stem Cell Biology, Frontiers Science Center for Disease-Related Molecular Network, Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China.ORCID 0009-0004-1790-2956
Qiaorong HuangLaboratory of Stem Cell Biology, Frontiers Science Center for Disease-Related Molecular Network, Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China.
Wentong MengLaboratory of Stem Cell Biology, Frontiers Science Center for Disease-Related Molecular Network, Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China.
Xue LiLaboratory of Stem Cell Biology, Frontiers Science Center for Disease-Related Molecular Network, Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China.
Lei ChenLaboratory of Stem Cell Biology, Frontiers Science Center for Disease-Related Molecular Network, Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China.ORCID 0000-0001-5263-5540
Xianming MoLaboratory of Stem Cell Biology, Frontiers Science Center for Disease-Related Molecular Network, Department of Neurology, West China Hospital, Sichuan University, Chengdu 610041, China.

Funding

West China Hospital of Sichuan University ZYGD23026West China Hospital of Sichuan University ZYJC21003
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

care cascadecross-national comparisondiabeteshealth equityhealth insurancehypertensionsocioeconomic status

Identifiers

PMID41754014
PMCPMC12940640

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.